https://www.businesswire.com/news/home/20231111701765/en/Cleerly-Partners-Announce-TRANSFORM-Trial-to-Evaluate-Personalized-Heart-Disease-Care-Strategies-at-American-Heart-Association-2023
Cleerly, Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies...
Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the TRANSFORM trial at the American Heart A...
heart disease caretransform trial